loadpatents
Patent applications and USPTO patent grants for MILES; David W..The latest application filed is for "lisinopril formulations".
Patent | Date |
---|---|
Lisinopril Formulations App 20220111000 - MOSHER; Gerold L. ;   et al. | 2022-04-14 |
Enalapril Formulations App 20220047549 - MOSHER; Gerold L. ;   et al. | 2022-02-17 |
Lisinopril formulations Grant 11,179,434 - Mosher , et al. November 23, 2 | 2021-11-23 |
Enalapril formulations Grant 11,173,141 - Mosher , et al. November 16, 2 | 2021-11-16 |
Enalapril formulations Grant 11,141,405 - Mosher , et al. October 12, 2 | 2021-10-12 |
Enalapril Formulations App 20210299092 - Mosher; Gerold L. ;   et al. | 2021-09-30 |
Enalapril Formulations App 20210251956 - Mosher; Gerold L. ;   et al. | 2021-08-19 |
Lisinopril Formulations App 20210187055 - MOSHER; Gerold L. ;   et al. | 2021-06-24 |
Enalapril formulations Grant 11,040,023 - Mosher , et al. June 22, 2 | 2021-06-22 |
Fractionated Alkylated Cyclodextrin Compositions And Processes For Preparing And Using The Same App 20210147582 - Antle; Vincent D. ;   et al. | 2021-05-20 |
Enalapril Formulations App 20210137882 - Mosher; Gerold L. ;   et al. | 2021-05-13 |
Lisinopril formulations Grant 10,940,177 - Mosher , et al. March 9, 2 | 2021-03-09 |
Enalapril formulations Grant 10,918,621 - Mosher , et al. February 16, 2 | 2021-02-16 |
Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same Grant 10,851,184 - Antle , et al. December 1, 2 | 2020-12-01 |
Enalapril Formulations App 20200368200 - MOSHER; Gerold L. ;   et al. | 2020-11-26 |
Enalapril formulations Grant 10,799,476 - Mosher , et al. October 13, 2 | 2020-10-13 |
Enalapril formulations Grant 10,786,482 - Mosher , et al. September 29, 2 | 2020-09-29 |
Enalapril formulations Grant 10,772,868 - Mosher , et al. September 15, 2 | 2020-09-15 |
Enalapril Formulations App 20200281893 - MOSHER; Gerold L. ;   et al. | 2020-09-10 |
Lisinopril Formulations App 20200237851 - MOSHER; Gerold L. ;   et al. | 2020-07-30 |
Lisinopril Formulations App 20200206298 - MOSHER; Gerold L. ;   et al. | 2020-07-02 |
Lisinopril formulations Grant 10,406,199 - Mosher , et al. Sept | 2019-09-10 |
Lisinopril Formulations App 20190201475 - MOSHER; Gerold L. ;   et al. | 2019-07-04 |
Enalapril Formulations App 20190142797 - MOSHER; Gerold L. ;   et al. | 2019-05-16 |
Lisinopril formulations Grant 10,265,370 - Mosher , et al. | 2019-04-23 |
Enalapril Formulations App 20190070147 - Mosher; Gerold L. ;   et al. | 2019-03-07 |
Enalapril formulations Grant 10,154,987 - Mosher , et al. Dec | 2018-12-18 |
Lisinopril Formulations App 20180339011 - MOSHER; Gerold L. ;   et al. | 2018-11-29 |
Enalapril Formulations App 20180289669 - MOSHER; Gerold L. ;   et al. | 2018-10-11 |
Lisinopril formulations Grant 10,039,800 - Mosher , et al. August 7, 2 | 2018-08-07 |
Enalapril formulations Grant 10,039,745 - Mosher , et al. August 7, 2 | 2018-08-07 |
Lisinopril Formulations App 20180078604 - MOSHER; Gerold L. ;   et al. | 2018-03-22 |
Enalapril Formulations App 20180055821 - MOSHER; Gerold L. ;   et al. | 2018-03-01 |
Lisinopril formulations Grant 9,814,751 - Mosher , et al. November 14, 2 | 2017-11-14 |
Enalapril formulations Grant 9,808,442 - Mosher , et al. November 7, 2 | 2017-11-07 |
Fractionated Alkylated Cyclodextrin Compositions And Processes For Preparing And Using The Same App 20170275388 - Antle; Vincent D. ;   et al. | 2017-09-28 |
Enalapril Formulations App 20170266159 - MOSHER; Gerold L. ;   et al. | 2017-09-21 |
Lisinopril Formulations App 20170209523 - MOSHER; Gerold L. ;   et al. | 2017-07-27 |
Enalapril formulations Grant 9,669,008 - Mosher , et al. June 6, 2 | 2017-06-06 |
Lisinopril Formulations App 20170119840 - MOSHER; Gerold L. ;   et al. | 2017-05-04 |
Lisinopril formulations Grant 9,616,096 - Mosher , et al. April 11, 2 | 2017-04-11 |
Lisinopril formulations Grant 9,463,183 - Mosher , et al. October 11, 2 | 2016-10-11 |
SEC | 0001169106 | MILES DAVID W |
SEC | 0001343388 | Miles David W |
SEC | 0001431460 | MILES DAVID W. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.